|
|
|
|
|
|
| |
| FDA Withdraws NDA for Mylotarg |
| 11/28/2011 |
| |
|
Federal Register Notice: FDA is withdrawing approval of a Wyeth Pharmaceuticals’ NDA for Mylotarg (gemtuzumab ozogamicin) for injection. Wyeth has voluntarily requested that approval of this application be withdrawn, thereby waiving its opportunity for a hearing. To view this notice, click here. |
| |
|
| |
| |
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.
|
|
RSS
